Bonus BioGroup Ltd. (BBIXF)

Market Cap	152.69M +161.4%
Revenue (ttm)	n/a
Net Income	-7.68M
EPS	-0.01
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	600
Open	0.1300
Previous Close	0.1400
Day's Range	0.1300 - 0.1300
52-Week Range	0.0001 - 0.1500
Beta	0.86
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 5, 2026

About Bonus BioGroup

Bonus BioGroup Ltd., a clinical-stage biotechnology company, develops products based on tissue engineering and cell therapy. The company’s products under development include BonoFill for the treatment of bone tissue regeneration in maxillofacial and orthopedic indications, and defects in limb and jaw bones which is in Phase II clinical trial, as well as in a preclinical stage for the treatment of bone augmentation in osteoporosis patients. It also develops MesenCure for the treatment of COVID patients suffering from pneumonia and ARDS which is ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1981
• Employees: 42
• Stock Exchange: OTCMKTS
• Ticker Symbol: BBIXF

Financial Performance

Financial numbers in ILS